title: Reply to "Comment on Neiser et al. Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA). Int. J. Mol. Sci. 2016, 17, 1185."
abstract: n/a.
authors.affiliation: Global Medical Affairs, Vifor Pharma Ltd., 8152 Glattbrugg, Switzerland. susanna.burckhardt@viforpharma.com.
authors.forename: Susanna
authors.initials: S
authors.lastname: Burckhardt
mesh_terms: D061605:Administration, Intravenous; D003911:Dextrans; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007501:Iron
chemical_list: D003911:Dextrans; D007501:Iron